T. Rowe Price Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $264M | Buy |
|
|||||
|
2025
Q2 | $91.9M | Buy |
|
|||||
|
2025
Q1 | $26.8M | Buy |
|
|||||
|
2024
Q4 | $2.95M | Sell |
|
|||||
|
2024
Q3 | $19.3M | Sell |
|
|||||
|
2024
Q2 | $39.7M | Sell |
|
|||||
|
2024
Q1 | $31.9M | Sell |
|
|||||
|
2023
Q4 | $49.2M | Sell |
|
|||||
|
2023
Q3 | $81.4M | Sell |
|
|||||
|
2023
Q2 | $151M | Buy |
|
|||||
|
2023
Q1 | $39.4M | Sell |
|
|||||
|
2022
Q4 | $46.3M | Buy |
|
|||||
|
2022
Q3 | $85.8M | Buy |
|
|||||
|
2022
Q2 | $63.4M | Buy |
|
|||||
|
2022
Q1 | $89M | Buy |
|
|||||
|
2021
Q4 | $131M | Sell |
|
|||||
|
2021
Q3 | $395M | Buy |
|
|||||
|
2021
Q2 | $196M | Buy |
|
|||||
|
2021
Q1 | $235M | Buy |
|
|||||
|
2020
Q4 | $185M | Buy |
|
|||||
|
2020
Q3 | $147M | Sell |
|
|||||
|
2020
Q2 | $119M | Sell |
|
|||||
|
2020
Q1 | $128M | Sell |
|
|||||
|
2019
Q4 | $242M | Buy |
|
|||||
|
2019
Q3 | $129M | Buy |
|
|||||
|
2019
Q2 | $151M | Buy |
|
|||||
|
2019
Q1 | $107M | Buy |
|
|||||
|
2018
Q4 | $52M | Buy |
|